Skip to main content
logo
Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.565
0.00 (0.00%)
Jul 29, 2026, 10:16 AM EDT - Market open

Alterity Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
8.847.644.023.925.124.49
Revenue Growth
15.67%90.12%2.63%-23.56%14.23%3554.58%
Gross Profit
8.847.644.023.925.124.49
Operating Income
-15.69-12.46-19.61-14.67-15.5-15.16
Net Income
-14.59-12.15-19.12-13.81-12.85-15.31
Earnings Per Share
-42.00-57.00-156.00-171.00-159.00-
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
49.233.1612.6415.7734.8128.12
Total Debt
0.10.160.160.210.120.07
Net Cash (Debt)
49.13312.4815.5634.6928.05
Net Cash Growth
48.78%164.45%-19.81%-55.13%23.67%206.12%
Net Cash Per Share
166.82154.78102.61192.31432.54-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-15.35-11.45-12.61-20.04-12.34-17.33
Capital Expenditures
0--0.01-0.01-0.09-0.01
Free Cash Flow
-15.35-11.45-12.61-20.04-12.43-17.34
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-177.49%-163.04%-487.82%-374.60%-302.56%-338.10%
Pretax Margin
-163.60%-158.08%-474.65%-349.87%-249.38%-341.33%
Profit Margin
-162.13%-157.19%-473.50%-347.20%-248.01%-341.33%
FCF Margin
-120.16%-149.86%-313.78%-511.78%-242.54%-386.62%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
17.4812.385.890.090.140.27